Yeast expressed, RBD-based vaccine provides robust immune responses against SARS-CoV-2

By | July 20, 2021
The ongoing coronavirus disease (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused over 190 million cases worldwide. Of these, over 4 million have died due to the infection.